bf/NASDAQ:MRNS_icon.jpeg

NASDAQ:MRNS

Marinus Pharmaceuticals, Inc.

  • Stock

USD

Last Close

0.36

08/11 21:00

Market Cap

67.57M

Beta: 1.16

Volume Today

887.72K

Avg: 544.92K

PE Ratio

−4.02

PFCF: −4.81

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.01
-
0.11
882.10%
0.10
12.45%
0.18
84.69%
cash conversion cycle
-2.99K
-
-6.63K
121.50%
-188.80
97.15%
cash per share
4.98
-
32.32
549.20%
15.07
53.39%
6.17
59.01%
9.07
46.92%
7.11
21.59%
6.73
5.42%
5.13
23.70%
3.35
34.74%
6.16
83.79%
2.80
54.58%
company equity multiplier
1.25
-
1.22
2.40%
1.27
4.21%
1.46
15.14%
1.05
28.56%
1.10
5.28%
1.13
2.27%
1.10
2.62%
2.56
133.29%
2.24
12.55%
10.19
355.67%
days of inventory outstanding
-2.30K
-
82.66
103.60%
354.42
328.76%
days of payables outstanding
771.98
-
6.81K
781.79%
587.97
91.36%
days of sales outstanding
349.70
-
75.78
78.33%
90.94
20.00%
44.75
50.80%
dividend yield
ebit per revenue
-39.54
-
-6.32
84.03%
-4.43
29.92%
-4.24
4.15%
ebt per ebit
0.98
-
0.91
7.24%
1.02
11.92%
1.01
0.29%
0.99
2.15%
0.99
0.46%
0.99
0.67%
0.99
0.13%
1.02
2.60%
0.15
85.71%
1.09
646.43%
effective tax rate
0.01
-
-0.12
2,389.18%
-0.02
84.41%
-0.01
26.03%
-0.00
95.06%
-0.01
1,693.07%
0.01
153.03%
0.01
88.74%
-0.03
336.51%
-0.21
606.59%
0.01
105.22%
enterprise value multiple
-10.54
-
-2.08
80.23%
-2.86
37.21%
0.04
101.54%
-8.46
19,284.16%
-1.36
83.97%
-0.50
62.89%
-2.87
469.41%
-3.68
28.36%
2.15
158.42%
-4.38
304.01%
fixed asset turnover
0.88
-
6.14
595.18%
6.01
2.05%
6.40
6.39%
free cash flow per share
-3.30
-
-5.61
70.04%
-5.49
2.04%
-5.21
5.05%
-3.27
37.21%
-2.73
16.57%
-3.60
31.69%
-2.23
37.90%
-1.59
28.79%
-2.93
84.51%
-2.20
25.11%
gross profit margin
1
-
0.90
9.63%
0.99
9.18%
0.92
6.77%
interest coverage
-59.36
-
-101.88
71.63%
-51.44
49.51%
-60.87
18.33%
-119.77
96.77%
-37.54
-
-10.57
71.85%
-7.78
26.36%
inventory turnover
-0.16
-
4.42
2,880.80%
1.03
76.68%
long term debt to capitalization
0.15
-
0.10
30.77%
0.08
25.41%
0.43
-
0.38
12.26%
0.85
123.90%
net income per ebt
1
-
1
0%
1
0%
1
0%
1
0%
1
0%
0.99
0.65%
0.99
0.58%
1.03
4.21%
1.21
17.21%
0.99
17.99%
net profit margin
-38.79
-
-6.62
82.92%
-0.78
88.26%
-4.56
486.69%
operating cash flow per share
-3.29
-
-5.58
69.83%
-5.40
3.35%
-5.08
5.84%
-3.20
37.08%
-2.72
14.82%
-3.57
31.04%
-2.23
37.41%
-1.51
32.32%
-2.89
91.11%
-2.20
24.01%
operating cycle
-2.22K
-
173.60
107.81%
399.17
129.93%
operating profit margin
-39.54
-
-6.32
84.03%
-4.43
29.92%
-4.24
4.15%
payables turnover
0.47
-
0.05
88.66%
0.62
1,057.76%
pretax profit margin
-39.28
-
-6.44
83.61%
-0.64
89.98%
-4.61
615.42%
price fair value
6.82
-
1.58
76.83%
2.43
53.73%
0.92
62.26%
3.31
261.18%
1.72
48.13%
1.34
21.90%
2.42
80.75%
8.15
236.14%
1.34
83.55%
34.85
2,499.43%
receivables turnover
1.04
-
4.82
361.45%
4.01
16.67%
8.16
103.24%
return on assets
-0.45
-
-0.22
51.59%
-0.42
93.06%
-0.91
118.68%
-0.31
65.80%
-0.49
56.72%
-0.54
11.43%
-0.44
18.58%
-0.74
67.73%
-0.08
89.72%
-0.83
983.56%
return on capital employed
-0.57
-
-0.25
56.49%
-0.47
89.06%
-1.21
158.41%
-0.33
72.90%
-0.54
66.10%
-0.60
10.13%
-0.49
18.87%
-1.01
107.08%
-0.55
45.26%
-1.01
83.11%
return on equity
-0.56
-
-0.26
52.76%
-0.53
101.20%
-1.33
151.79%
-0.33
75.57%
-0.54
64.99%
-0.61
13.97%
-0.49
20.71%
-1.90
291.30%
-0.17
91.01%
-8.43
4,837.46%
total debt to capitalization
0.15
-
0.14
6.53%
0.20
44.40%
0.01
-
0.00
26.75%
0.44
11,675.61%
0.39
11.68%
0.87
125.21%

All numbers in USD (except ratios and percentages)